HCW Biologics Inc
HCWB
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.27M
Close$
$-2.35
317.6% downside
Current Fair Value
317.6% downsideOvervalued by 317.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.27 Million |
|---|---|
| Enterprise Value | $8.09 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-10.63 |
| Beta | 2.21 |
| Outstanding Shares | 2,097,701 |
Return
| Return on Equity | -453.33% |
|---|---|
| Return on Assets | -95.54% |
| Return on Invested Capital | -123.49% |
Valuation & Multiples
| P/E Ratio | -0.13 |
|---|---|
| PEG | 0.04 |
| Price to Sales | 0.36 |
| Price to Book Ratio | 0.54 |
| Enterprise Value to Revenue | 1.23 |
| Enterprise Value to EBIT | -0.89 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.87 |
| Debt to Equity | 1.22 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.44
Average shareholder expectationRevenue Estimate
$6.54 M
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$5.73 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 21.44%▲ 0.62% |
|---|---|
| Total Invested | $160,832▼ 62.08% |
| Investors Holding | 140% |
ESG Score
No data
About HCW Biologics Inc
40 employees